The incidence of<unk><unk>  is approximately 0.6-2.5 cases per 100,000 individuals worldwide annually. The prevalence of<unk><unk>  is about 30 for every 100,000 people worldwide. The incidence of<unk><unk>  increases with age; the median age at diagnosis is 65-70 years. Patients of all age groups may develop<unk><unk> . However it commonly affects individuals older than 60 years of age. Females are more commonly affected with<unk><unk>  than males. The female to male ratio is approximately 2 to 1.
Essential thrombocytosis epidemiology and demographics
Polycythemia vera epidemiology and demographics
Thrombotic thrombocytopenic purpura epidemiology and demographics
Idiopathic thrombocytopenic purpura epidemiology and demographics
Von Willebrand disease epidemiology and demographics
Polycythemia epidemiology and demographics
Glanzmann's thrombasthenia epidemiology and demographics
Thrombophilia epidemiology and demographics